Comparison of Different Up-dosing Schedules With Osiris

NCT01240954 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

210

Enrollment

INDUSTRY

Sponsor class

Stopped CA approval not obtained

Conditions

Allergic Rhinitis

Interventions

DRUG: OSIRIS
DRUG: OSIRIS other concentration 1
DRUG: OSIRIS other concentration 2

Sponsor

ALK-Abelló A/S